TY - JOUR
T1 - Significant differences in IBD care and education across Europe
T2 - results of the pan-European VIPER survey
AU - Pan-European VIPER Survey Group
AU - Verstockt, Bram
A2 - Kral, Jan
A2 - Nakov, Radislav
A2 - Lanska, Vera
A2 - Barberio, Brigida
A2 - Benech, Nicolas
A2 - Blesl, Andreas
A2 - Brunet, Eduard
A2 - Capela, Tiago
A2 - Derikx, Lauranne
A2 - Dragoni, Gabriele
A2 - Eek, Aileen
A2 - Frias-Gomes, Catarina
A2 - Gîlcă-Blanariu, Georgiana-Emmanuela
A2 - Gilroy, Leah
A2 - Harvey, Philip
A2 - Kagramanova, Anna
A2 - Kani, Haluk
A2 - Konikoff, Tom
A2 - Lessing, Matthias
A2 - Madsen, Gorm
A2 - Maksimaityte, Vaidota
A2 - Miasnikova, Maria
A2 - Mikolašević, Ivana
A2 - Milivojevic, Vladimir
A2 - Noviello, Daniele
A2 - Oliinyk, Dmytro
A2 - Patai, Arpad
A2 - Pisani, Anthea
A2 - Protopapas, Adonis
A2 - Rodríguez-Lago, Iago
A2 - Schreiner, Philipp
A2 - Skuja, Vita
A2 - Tran, Florian
A2 - Truyens, Marie
A2 - Włodarczyk, Marcin
A2 - Zatorski, Hubert
A2 - Segal, Jonathan Philip
N1 - S. Karger AG, Basel.
PY - 2023/5
Y1 - 2023/5
N2 - BACKGROUND: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries.METHODS: This trainee-initiated survey, run through SurveyMonkey®, consisted of 47 questions inquiring basic demographics, IBD training, and clinical care. Results were compared according to gross domestic product (GDP) per capita, for which countries were divided into 2 groups (low/high income, according to the World Bank).RESULTS: The online survey was completed by 1285 participants from 40 European countries, with a majority of specialists (65.3%) working in academic institutions (50.4%). Significant differences in IBD-specific training (55.9% vs. 38.4%), as well as availability of IBD units (58.4% vs. 39.7%) and multidisciplinary meetings (73.2% vs. 40.1%) were observed between respondees from high and low GDP countries (p<0.0001). In high GDP countries, IBD nurses are more common (85.9% vs. 36.0%), also mirrored by more nurse-led IBD clinics (40.6% vs. 13.7%; p<0.0001). IBD dieticians (33.4% vs. 16.5%) and psychologists (16.8% vs. 7.5%) are mainly present in high GDP countries (p<0.0001). In the current COVID era, telemedicine is available in 73.2% vs. 54.1% of the high/low GDP countries respectively (p<0.0001). Treat-to-target approaches are implemented everywhere (85.0%), though access to biologicals and small molecules differs significantly.CONCLUSION: Much variability in IBD practice exists across Europe, with marked differences between high vs. low GDP countries. Further work is required to help address some of these inequalities, aiming to improve and standardize IBD care and training across Europe.
AB - BACKGROUND: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries.METHODS: This trainee-initiated survey, run through SurveyMonkey®, consisted of 47 questions inquiring basic demographics, IBD training, and clinical care. Results were compared according to gross domestic product (GDP) per capita, for which countries were divided into 2 groups (low/high income, according to the World Bank).RESULTS: The online survey was completed by 1285 participants from 40 European countries, with a majority of specialists (65.3%) working in academic institutions (50.4%). Significant differences in IBD-specific training (55.9% vs. 38.4%), as well as availability of IBD units (58.4% vs. 39.7%) and multidisciplinary meetings (73.2% vs. 40.1%) were observed between respondees from high and low GDP countries (p<0.0001). In high GDP countries, IBD nurses are more common (85.9% vs. 36.0%), also mirrored by more nurse-led IBD clinics (40.6% vs. 13.7%; p<0.0001). IBD dieticians (33.4% vs. 16.5%) and psychologists (16.8% vs. 7.5%) are mainly present in high GDP countries (p<0.0001). In the current COVID era, telemedicine is available in 73.2% vs. 54.1% of the high/low GDP countries respectively (p<0.0001). Treat-to-target approaches are implemented everywhere (85.0%), though access to biologicals and small molecules differs significantly.CONCLUSION: Much variability in IBD practice exists across Europe, with marked differences between high vs. low GDP countries. Further work is required to help address some of these inequalities, aiming to improve and standardize IBD care and training across Europe.
UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000890024900001
UR - http://www.scopus.com/inward/record.url?scp=85152674936&partnerID=8YFLogxK
U2 - 10.1159/000528070
DO - 10.1159/000528070
M3 - Article
C2 - 36412565
SN - 0257-2753
VL - 41
SP - 387
EP - 395
JO - Digestive Diseases
JF - Digestive Diseases
IS - 3
ER -